News

Ablacon Inc. announced that it has entered into a $10 million venture debt facility with Western Technology Investment (WTI). The debt is accompanied by a $2 million equity investment in the Company. This financing will help fund Ablacon's...

BIOTRONIK announced the publication of the SENSE Trial results in the Journal of Cardiovascular Electrophysiology, proving BIOTRONIK's DX system is equivalent to dual-chamber implantable cardioverter defibrillators (ICDs) in detecting atrial...

BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, announced that it will be receiving 15...

Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and Electrophysiology. The study demonstrated 73 percent single-procedure freedom from atrial fibrillation (AF) at 12 months with the use of Acutus'...

Boehringer Ingelheim announced results from two pediatric studies of Pradaxa®, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia. The Phase IIb/III DIVERSITY...

BIOTRONIK announced FDA clearance of the BIOMONITOR III injectable cardiac monitor (ICM). BIOMONITOR III is designed to document suspected arrhythmia or unexplained syncope with increased clarity, enabling fast diagnosis and appropriate...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced new results from the Phase 3 EINSTEIN-Jr study, showing pediatric patients (aged birth to 17 years) treated with XARELTO® (rivaroxaban) had a similar low risk of...

Innovative Health, the leading single-use cardiology medical device reprocessing company, announced it has received FDA clearance for reprocessing the Webster Duo-Decapolar Diagnostic EP Catheter. The 20-electrode EP catheter is used in...

BIOTRONIK announced the market release of its new injectable cardiac monitor (ICM), BIOMONITOR III, following approval in the CE region. The novel device is designed to help patients with irregular heart rhythms by documenting suspected...

Veradigm™, an Allscripts, business unit dedicated to simplifying healthcare with data-driven health insights and technologies to help manage costs and improve health outcomes, announced that it has partnered with the American College of...